S
3.82
0.30 (8.52%)
| Penutupan Terdahulu | 3.52 |
| Buka | 3.46 |
| Jumlah Dagangan | 5,189,066 |
| Purata Dagangan (3B) | 2,860,970 |
| Modal Pasaran | 1,019,431,552 |
| Harga / Buku (P/B) | 5.52 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| EPS Cair (TTM) | -0.880 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 43.67% |
| Nisbah Semasa (MRQ) | 3.40 |
| Aliran Tunai Operasi (OCF TTM) | -206.18 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -118.45 M |
| Pulangan Atas Aset (ROA TTM) | -23.84% |
| Pulangan Atas Ekuiti (ROE TTM) | -71.44% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Sana Biotechnology, Inc. | Menurun | Bercampur |
AISkor Stockmoo
-0.4
| Konsensus Penganalisis | -0.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -1.0 |
| Osilator Teknikal | 2.0 |
| Purata | -0.38 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 8.46% |
| % Dimiliki oleh Institusi | 89.37% |
| Julat 52 Minggu | ||
| Median | 7.00 (83.25%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 04 Mar 2026 | 7.00 (83.25%) | Beli | 3.82 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |